DE602005020501D1 - Vernetzte aminpolymere - Google Patents

Vernetzte aminpolymere

Info

Publication number
DE602005020501D1
DE602005020501D1 DE602005020501T DE602005020501T DE602005020501D1 DE 602005020501 D1 DE602005020501 D1 DE 602005020501D1 DE 602005020501 T DE602005020501 T DE 602005020501T DE 602005020501 T DE602005020501 T DE 602005020501T DE 602005020501 D1 DE602005020501 D1 DE 602005020501D1
Authority
DE
Germany
Prior art keywords
aminpolymers
networked
methods
treatment
polymeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005020501T
Other languages
English (en)
Inventor
Han Ting Chang
Dominique Charmot
Eric Connor
Florence Roger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ilypsa Inc
Original Assignee
Ilypsa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/965,044 external-priority patent/US7459502B2/en
Priority claimed from US10/980,991 external-priority patent/US7608674B2/en
Application filed by Ilypsa Inc filed Critical Ilypsa Inc
Publication of DE602005020501D1 publication Critical patent/DE602005020501D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/01—Use of inorganic substances as compounding ingredients characterized by their specific function
    • C08K3/011—Crosslinking or vulcanising agents, e.g. accelerators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
DE602005020501T 2004-10-13 2005-05-11 Vernetzte aminpolymere Active DE602005020501D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/965,044 US7459502B2 (en) 2003-11-03 2004-10-13 Pharmaceutical compositions comprising crosslinked polyamine polymers
PCT/US2004/036745 WO2005041902A2 (en) 2003-11-03 2004-11-03 Anion-binding polymers and uses thereof
US10/980,991 US7608674B2 (en) 2003-11-03 2004-11-03 Pharmaceutical compositions comprising cross-linked small molecule amine polymers
PCT/US2005/009394 WO2005092039A2 (en) 2004-03-22 2005-03-22 Crosslinked amine polymers
PCT/US2005/016437 WO2006043984A2 (en) 2004-10-13 2005-05-11 Crosslinked amine polymers

Publications (1)

Publication Number Publication Date
DE602005020501D1 true DE602005020501D1 (de) 2010-05-20

Family

ID=36203360

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020501T Active DE602005020501D1 (de) 2004-10-13 2005-05-11 Vernetzte aminpolymere

Country Status (10)

Country Link
EP (1) EP1831266B1 (de)
JP (1) JP2008531751A (de)
CN (1) CN101065409A (de)
AT (1) ATE463528T1 (de)
AU (1) AU2005296290A1 (de)
CA (1) CA2583634C (de)
DE (1) DE602005020501D1 (de)
ES (1) ES2342947T3 (de)
MX (1) MX2007004407A (de)
WO (1) WO2006043984A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
WO2009023544A2 (en) * 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
JP5332520B2 (ja) * 2007-11-07 2013-11-06 アステラス製薬株式会社 医薬用錠剤
AU2011220748B2 (en) * 2010-02-24 2015-11-05 Relypsa, Inc. Amine polymers for use as bile acid sequestrants
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CN102342955A (zh) * 2011-08-04 2012-02-08 昆明邦宇制药有限公司 一种治疗高磷血症的药物组合物及其制剂
CN102675510B (zh) * 2012-05-28 2014-04-02 诚达药业股份有限公司 司维拉姆的合成工艺
EP3287133B1 (de) * 2013-06-05 2019-04-17 Tricida Inc. Protonenbindende polymere zur oralen verabreichung
EP3698799B1 (de) * 2017-10-16 2022-01-26 FUJIFILM Corporation Mittel zur behandlung von hyperphosphatämie
CA3079171C (en) * 2017-10-16 2023-09-12 Fujifilm Corporation Therapeutic agent for hyperphosphatemia and particles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
FR2680791B1 (fr) * 1991-08-30 1994-09-09 Bp Chemicals Snc Procede de fabrication d'un polymere reticule et utilisation du polymere.
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US6646083B2 (en) * 2000-06-16 2003-11-11 Nippon Shokubai Co., Ltd. Crosslinked polymers containing tertiary amine and/or quaternary ammonium salt structures, processes for making and uses thereof
JP3931639B2 (ja) * 2001-11-19 2007-06-20 セイコーエプソン株式会社 インクジェットプリンタに使用するための水性インク組成物
CA2412691C (en) * 2002-11-25 2008-02-26 Mac & Mac Hydrodemolition Inc. Scarifying apparatus for interior surface of pipeline

Also Published As

Publication number Publication date
CA2583634C (en) 2013-03-19
EP1831266A2 (de) 2007-09-12
AU2005296290A1 (en) 2006-04-27
WO2006043984A2 (en) 2006-04-27
EP1831266A4 (de) 2007-12-05
CN101065409A (zh) 2007-10-31
EP1831266B1 (de) 2010-04-07
CA2583634A1 (en) 2006-04-27
WO2006043984A3 (en) 2006-08-24
ES2342947T3 (es) 2010-07-19
MX2007004407A (es) 2007-07-17
JP2008531751A (ja) 2008-08-14
ATE463528T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
DE602005020501D1 (de) Vernetzte aminpolymere
WO2005092039A3 (en) Crosslinked amine polymers
GB2430368B (en) Methods and compositions for treatment of ion imbalances
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
GB2446076A (en) Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
WO2006058868A3 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
TW200722098A (en) Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in pharmaceutical compositions for treating cancer
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2005085188A3 (en) Compounds and methods for anti-tumor therapy
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
WO2005000208A3 (en) Combination therapy for the treatment of neoplasms
WO2007038801A3 (en) Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
WO2008008491A3 (en) Implantable medical devices and coatings therefor comprising physically crosslinked block copolymers
TW200716561A (en) P38 inhibitors and methods of use thereof
HK1106133A1 (en) Ion binding compositions
DE602005011029D1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien
TW200635580A (en) Methods of treatment and prevention
WO2004073631A3 (en) Combination therapy for the treatment of neoplasms
AU2003301174A8 (en) Liposomal analgesic formulation and use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition